Plin Catherine, Haddad Pierre S, Tillement Jean-Paul, Elimadi Aziz, Morin Didier
Laboratoire de Pharmacologie, Faculté de Médecine, Université Paris XII, France.
Eur J Pharmacol. 2004 Jul 14;495(2-3):111-8. doi: 10.1016/j.ejphar.2004.05.042.
Liver transplantation is an effective therapeutic option for end-stage liver disease, but initial poor graft function still occurs, often related to cold preservation-warm reperfusion (CPWR) conditions. Damages to mitochondria could be implicated in hepatocyte cell death since opening of the permeability transition pore (PTP) can lead to necrosis and apoptosis. The purpose of this study was to test the hypothesis that inhibition of mitochondrial permeability transition by cyclosporin A could improve rat liver mitochondrial and hepatocellular parameters after 24-h cold preservation followed by a warm reperfusion in Krebs-Henseleit Buffer. Mitochondrial functions were assessed by measuring respiratory parameters, swelling, cytochrome c release and caspases activation. Hepatocyte injury was assessed by evaluation of ATP energetic charge, lactate dehydrogenase (LDH) leakage, apoptosis and necrosis. Results show that CPWR induces liver mitochondrial and cellular damages. CPWR induced damages on the mitochondrial respiratory chain, leading to mitochondrial swelling. The consequences are the loss of ATP energetic charge, the initiation of apoptosis through cytochrome c release and the activation of caspases. Cyclosporin A partially protects respiratory chain integrity and totally prevents mitochondrial swelling, allowing better recovery of energetic charge. It also partially limits the activation of the apoptotic machinery and subsequent cell death by apoptosis in both the organ and isolated hepatocytes. Inhibition of permeability transition thus provides only partial protection against CPWR. However, this target can be considered as a promising adjunct therapeutic approach to improve the primary function of the grafted liver after transplantation.
肝移植是终末期肝病的一种有效治疗选择,但初始移植物功能不良仍会发生,这通常与冷保存-热再灌注(CPWR)条件有关。线粒体损伤可能与肝细胞死亡有关,因为通透性转换孔(PTP)的开放可导致坏死和凋亡。本研究的目的是检验以下假设:环孢素A抑制线粒体通透性转换可改善大鼠肝脏在24小时冷保存后,接着在Krebs-Henseleit缓冲液中进行热再灌注后的线粒体和肝细胞参数。通过测量呼吸参数、肿胀、细胞色素c释放和半胱天冬酶激活来评估线粒体功能。通过评估ATP能量电荷、乳酸脱氢酶(LDH)泄漏、凋亡和坏死来评估肝细胞损伤。结果表明,CPWR会导致肝脏线粒体和细胞损伤。CPWR会对线粒体呼吸链造成损伤,导致线粒体肿胀。其后果是ATP能量电荷丧失、通过细胞色素c释放引发凋亡以及半胱天冬酶激活。环孢素A可部分保护呼吸链完整性,并完全防止线粒体肿胀,使能量电荷能更好地恢复。它还能部分限制凋亡机制的激活以及随后器官和分离肝细胞中因凋亡导致的细胞死亡。因此,抑制通透性转换仅能对CPWR提供部分保护。然而,这一靶点可被视为一种有前景的辅助治疗方法,以改善移植后移植肝脏的初级功能。